Alterations to the Cardiac Metabolome Induced by Chronic T. cruzi Infection Relate to the Degree of Cardiac Pathology

An Updated Review of Pro- and Anti-Inflammatory Properties of Plasma Lysophosphatidylcholines in the Vascular System

(2020) Eva Knuplez et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Mapping of host-parasite-microbiome interactions reveals metabolic determinants of tropism and tolerance in Chagas disease

(2020) E. Hossain et al.   Science Advances

Feature-based molecular networking in the GNPS analysis environment

(2020) Louis-Félix Nothias et al.   NATURE METHODS

Improved Biomarker and Imaging Analysis for Characterizing Progressive Cardiac Fibrosis in a Mouse Model of Chronic Chagasic Cardiomyopathy

(2019) Kristyn A. Hoffman et al.   Journal of the American Heart Association

Diet Alters Serum Metabolomic Profiling in the Mouse Model of Chronic Chagas Cardiomyopathy

(2019) Kezia Lizardo et al.   DISEASE MARKERS

Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease

(2018) Kathryn Jones et al.   INFECTION AND IMMUNITY

Chagas disease

(2018) Dan M. Tzizik et al.   JAAPA-Journal of the American Academy of Physician Assistants

Alpha linolenic acid decreases apoptosis and oxidized phospholipids in cardiomyocytes during ischemia/reperfusion

(2017) Riya Ganguly et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Plasma acylcarnitines and risk of cardiovascular disease: effect of Mediterranean diet interventions

(2016) Marta Guasch-Ferré et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Cardiac Magnetic Resonance-Verified Myocardial Fibrosis in Chagas Disease: Clinical Correlates and Risk Stratification

(2016) Marly Uellendahl et al.   Arquivos Brasileiros de Cardiologia

Proteins involved on TGF-β pathway are up-regulated during the acute phase of experimental Chagas disease

(2016) Roberto Rodrigues Ferreira et al.   IMMUNOBIOLOGY

Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking

(2016) Mingxun Wang et al.   NATURE BIOTECHNOLOGY

A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease

(2016) Meagan A. Barry et al.   Human Vaccines & Immunotherapeutics

Early Regulation of Profibrotic Genes in Primary Human Cardiac Myocytes by Trypanosoma cruzi

(2016) Aniekanabassi N. Udoko et al.   PLoS Neglected Tropical Diseases

The ImageJ ecosystem: An open platform for biomedical image analysis

(2015) Johannes Schindelin et al.   MOLECULAR REPRODUCTION AND DEVELOPMENT

Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy

(2015) Carlos A. Morillo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trypanosoma cruzi Infection through the Oral Route Promotes a Severe Infection in Mice: New Disease Form from an Old Infection?

(2015) Juliana Barreto-de-Albuquerque et al.   PLoS Neglected Tropical Diseases

Chagas Disease Cardiomyopathy: Immunopathology and Genetics

(2014) Edecio Cunha-Neto et al.   MEDIATORS OF INFLAMMATION

Global Metabolomic Profiling of Acute Myocarditis Caused by Trypanosoma cruzi Infection

(2014) Núria Gironès et al.   PLoS Neglected Tropical Diseases

The Reality of Heart Failure in Latin America

(2013) Edimar Alcides Bocchi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk

(2013) W.H. Wilson Tang et al.   NEW ENGLAND JOURNAL OF MEDICINE

EMPeror: a tool for visualizing high-throughput microbial community data

(2013) Yoshiki Vázquez-Baeza et al.   GigaScience

Trypanosoma cruzi, the causative agent of Chagas disease, modulates interleukin-6-induced STAT3 phosphorylation via gp130 cleavage in different host cells

(2012) Nicolás Eric Ponce et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

A cross-platform toolkit for mass spectrometry and proteomics

(2012) Matthew C Chambers et al.   NATURE BIOTECHNOLOGY

Global metabolic profiling of animal and human tissues via UPLC-MS

(2012) Elizabeth J Want et al.   Nature Protocols

Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease

(2012) Fabiana S. Machado et al.   Seminars in Immunopathology

Oral Administration of GW788388, an Inhibitor of Transforming Growth Factor Beta Signaling, Prevents Heart Fibrosis in Chagas Disease

(2012) Fabiane L. de Oliveira et al.   PLoS Neglected Tropical Diseases

A Soluble Factor from Trypanosoma cruzi Inhibits Transforming Growth Factor-ß-Induced MAP Kinase Activation and Gene Expression in Dermal Fibroblasts

(2011) G. Adam Mott et al.   PLoS One

MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data

(2010) Tomáš Pluskal et al.   BMC BIOINFORMATICS

Chagas disease

(2010) Anis Rassi et al.   LANCET

QIIME allows analysis of high-throughput community sequencing data

(2010) J Gregory Caporaso et al.   NATURE METHODS

Pharmacological Inhibition of Transforming Growth Factor   Signaling Decreases Infection and Prevents Heart Damage in Acute Chagas' Disease

(2009) M. C. Waghabi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The clinical anatomy of the coronary collateral circulation

(2008) Marios Loukas et al.   CLINICAL ANATOMY

Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy

(2007) Maria do Carmo P. Nunes et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY